Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21757654rdf:typepubmed:Citationlld:pubmed
pubmed-article:21757654lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C0014257lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C0907532lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C0248719lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C1412113lld:lifeskim
pubmed-article:21757654lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:21757654pubmed:issue10lld:pubmed
pubmed-article:21757654pubmed:dateCreated2011-9-15lld:pubmed
pubmed-article:21757654pubmed:abstractTextContinuous administration of nitroglycerin (GTN) causes tolerance and endothelial dysfunction by inducing reactive oxygen species (ROS) production from various enzymatic sources, such as mitochondria, NADPH oxidase, and an uncoupled endothelial nitric oxide synthase (eNOS). In the present study, we tested the effects of type 1 angiotensin (AT(1))-receptor blockade with telmisartan on GTN-induced endothelial dysfunction in particular on eNOS phosphorylation and S-glutathionylation sites and the eNOS cofactor synthesizing enzyme GTP-cyclohydrolase I.lld:pubmed
pubmed-article:21757654pubmed:languageenglld:pubmed
pubmed-article:21757654pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:citationSubsetIMlld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757654pubmed:statusMEDLINElld:pubmed
pubmed-article:21757654pubmed:monthOctlld:pubmed
pubmed-article:21757654pubmed:issn1524-4636lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:ScholzAlexand...lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:DaiberAndreas...lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:SchulzEberhar...lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:MünzelThomasTlld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:GoriTommasoTlld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:HausdingMicha...lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:OelzeMatthias...lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:WenzelPhilipPlld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:KnorrMaikeMlld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:StevenSebasti...lld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:HeerenTjeboTlld:pubmed
pubmed-article:21757654pubmed:authorpubmed-author:Kröller-Schuh...lld:pubmed
pubmed-article:21757654pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21757654pubmed:volume31lld:pubmed
pubmed-article:21757654pubmed:ownerNLMlld:pubmed
pubmed-article:21757654pubmed:authorsCompleteYlld:pubmed
pubmed-article:21757654pubmed:pagination2223-31lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:meshHeadingpubmed-meshheading:21757654...lld:pubmed
pubmed-article:21757654pubmed:year2011lld:pubmed
pubmed-article:21757654pubmed:articleTitleNitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.lld:pubmed
pubmed-article:21757654pubmed:affiliationSecond Medical Clinic, Department of Cardiology, Medical Center of Johannes Gutenberg University, Mainz, Germany.lld:pubmed
pubmed-article:21757654pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21757654pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:24600entrezgene:pubmedpubmed-article:21757654lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21757654lld:entrezgene